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Using a large, passive, febrile surveillance program in Iq-
uitos, Peru, we retrospectively tested human blood speci-
mens for scrub typhus group orientiae by ELISA, immu-
nofluorescence assay, and PCR. Of 1,124 participants, 60 
(5.3%) were seropositive, and 1 showed evidence of recent 
active infection. Our serologic data indicate that scrub ty-
phus is present in the Peruvian Amazon.
Infections with scrub typhus group orientiae (STGO) are a common and widespread cause of fever in Asia, the 
western Pacific, and northern Australia (the tsutsugamushi 
triangle). The causative pathogen, Orientia tsutsugamushi, 
is transmitted by the larval stage of trombiculid mites of 
the genus Leptobromidium (chiggers). Clinical manifesta-
tions can be mild and unspecific, but complications include 
jaundice, meningoencephalitis, myocarditis, and interstitial 
pneumonia leading to acute respiratory distress syndrome 
and renal failure (1).
Epidemiologic studies in Southeast Asia have iden-
tified rickettsial illness (especially scrub typhus and mu-
rine typhus) as leading causes of treatable undifferentiat-
ed febrile illness, although they are often misdiagnosed 
as malaria, dengue, or typhoid fever (2). The causative 
agent of scrub typhus was not believed to exist outside 
the tsutsugamushi triangle until Orientia spp. were iden-
tified by serologic and molecular methods in febrile pa-
tients from the Middle East (3) and Chile (4). Recently, 
more autochthonous cases of scrub typhus were reported 
from Chiloé Island in southern Chile, suggesting ende-
micity in the area (5). Therefore, we conducted a study 
to obtain serologic evidence of scrub typhus in the Pe-
ruvian Amazon.
The Study
This study was conducted in Iquitos, which is located in the 
Amazon forest in the Department of Loreto in northeast-
ern Peru, where ongoing epidemiologic studies on febrile 
illness and rickettsial disease (6,7) have been conducted. 
STGO testing was nested in an ongoing febrile surveillance 
study (NMRCD.2010.0010), which was approved by the 
US Naval Medical Research Unit No. 6 Institutional Re-
view Board (Lima, Peru). The current study protocol was 
approved by the US Naval Medical Research Unit No. 6 
Institutional Review Board in compliance with all appli-
cable federal regulations governing the protection of hu-
man subjects.
Febrile surveillance was conducted in 12 health facil-
ities (3 hospitals and 9 outpatient clinics; 2 of the 12 were 
military facilities) distributed across 4 districts of Iquitos. 
Febrile patients who fulfilled the inclusion criteria (ax-
illary temperature >37.5°C, duration of illness <5 days, 
and age >5 years) were asked to participate in the study. 
An acute-phase blood sample was collected at the time of 
enrollment, and a convalescent-phase blood sample was 
obtained 10–30 days later. These samples had already 
been used for detection of other pathogens (mainly den-
gue virus and other arboviruses), and results and testing 
methods have been reported (8).
We retrospectively screened convalescent-phase blood 
samples obtained from participants enrolled during 2013 
by using an STGO-specific IgG ELISA. We screened 
convalescent-phase samples for IgG against a mixture of 
whole-cell antigen preparations from Karp, Kato, and Gil-
liam strains of O. tsutsugamushi in an STGO-specific IgG 
ELISA as described (9–11). For convalescent-phase sam-
ples with net absorbance >0.500 at a 1:100 serum dilution, 
we subsequently assessed STGO IgG ELISA titer (range 
1:100–1:6,400) with their paired acute-phase samples side-
by-side to determine their endpoint titers. We considered 
samples with a net total absorbance >1.000 for serum dilu-
tions 1:100, 1:400, 1:1,600, and 1:6,400 titer positive. We 
classified samples with a seroconversion or a >4-fold in-
crease in IgG titer between acute-phase and convalescent-
phase blood samples and minimum titer of 1:400 in the 
convalescent-phase sample as indicative of active rickett-
sial infection (11).
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DISPATCHES
Samples with evidence of active infection were then 
confirmed by immunofluorescence assay (IFA) with the 
Orientia MIF IgG Kit (Fuller Laboratories, Fullerton, CA, 
USA) and Karp, Kato, Gilliam, and Boryong strains of O. 
tsutsugamushi according to the manufacturer’s instructions. 
We further tested acute-phase samples with evidence for ac-
tive infection by PCR to identify the causative pathogen.
We extracted DNA from whole blood samples by 
using QIAmp DNA Mini Kits (QIAGEN, Valencia, CA, 
USA) following the manufacturer’s instructions except that 
a final elution volume of 100 µL was used. Samples were 
stored at −80°C. We assessed DNA samples from persons 
with evidence for recent active disease by using a quantita-
tive PCR specific for the O. tsutsugamuchi 47-kD antigen 
gene as reported (12).
During 2013, we enrolled 1,497 participants in the main 
study. Of these participants, 1,124 had paired serum sam-
ples. Results of the STGO-specific IgG were positive for 60 
(5.3%) of 1,124 convalescent-phase serum samples with a 
titer >1:400. One participant had a >4-fold increase in titer 
(acute-phase sample titer 1:400, convalescent-phase sample 
titer >6,400) and was confirmed by IFA as showing a >4-
fold increase in titer for 3 of 4 strains of O. tsutsugamushi 
(Karp, Gilliam, and Boryong) and a 2-fold increase in titer 
for the Kato strain. A test result of the acute-phase sample 
for Orientia sp. DNA was negative. This case-patient was a 
22-year-old soldier stationed in a rural military camp at the 
time of illness. He had fever, chills, malaise, muscle pain, 
nausea, and vomiting but no rash or jaundice. The patient 
had not traveled in the 2 weeks before illness and therefore 
could not have contracted the infection elsewhere.
Conclusions
We performed a retrospective systematic analysis for the 
presence of scrub typhus in Iquitos, Peru, by testing blood 
samples collected prospectively during unspecific acute 
febrile illness. Although definitive molecular evidence of 
Orientia spp. infection was not found, our serologic evi-
dence strongly suggests the presence of this pathogen in 
tropical areas of Peru.
Seroprevalence among febrile illness patients was low, 
especially because most patients tested came from urban 
rather than rural areas. In addition, our study design could 
further underestimate scrub typhus because we only includ-
ed patients with fever for <5 days, whereas the mean time 
to signs of scrub typhus has been reported as 8.2 days (13). 
Although the 1 patient with ELISA and IFA evidence of se-
roconversion showed a negative result by PCR, a negative 
PCR result during the acute phase of scrub typhus is not un-
common, even when testing is performed on whole blood or 
buffy coat samples (14). In addition, whether the causative 
agents of scrub typhus in South America are recognized by 
the primer set used in the quantitative PCR is unknown (4).
Cross-reactivity with other Rickettsia spp. does not 
seem to be a concern. The Orientia spp. ELISA using the 
immunodominant genus-specific, 56-kDa, type-specific an-
tigen (outer membrane protein [Omp]) does not react with 
antibodies produced during typhus group rickettsiae (TGR) 
and spotted fever group rickettsiae (SFGR) infections be-
cause rickettsiae lack the 56-kDa type-specific antigen. Sim-
ilarly, antibodies produced against Orientia spp. infection 
do not react against SFGR and TGR ELISA antigens (lipo-
polysaccharides OmpA and OmpB), because Orientia spp. 
do not contain these antigens (15). As expected, screening 
results for SFGR and TGR (7) were negative for the case-
patient we report.
Dengue virus and other arboviruses were excluded (by 
PCR or virus isolation) as alternative causes of fever. Fur-
thermore, study participants had probably already received 
over-the-counter medications, including antimicrobial 
drugs, which would account for false-negative PCR results. 
According to the prospectively collected clinical data, a 
typical rash was not documented for the case-patient we 
report. However, because this surveillance study was not 
directed toward scrub typhus features, a small eschar could 
have been easily missed.
This study raises many new issues, such as possible 
local reservoirs and vectors. The presence of trombiculide 
mites in Peru has been reported in other areas (16), but this 
species has not been studied as a local vector for pathogens. 
The case-patient we report was in the military and stationed 
in a rural camp. Therefore, he was regularly exposed to 
typical vegetation that supports the presence of mites. Our 
results and those from studies in Chile (4,5) indicate a need 
for a more expansive survey for evidence of scrub typhus, 
not only in Peru, but throughout South America.
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Ticks transmit a variety of different patho-
gens including bacteria, protozoa, and viruses, 
which can produce serious and even fatal dis-
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of cases of tickborne disease are reported 
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fever, headache, malaise, and sometimes 
rash. If left untreated, some of these diseases 
can be rapidly fatal.
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